Vanda Pharmaceuticals, Inc. (VNDA)
6.60
-0.15
(-2.22%)
USD |
NASDAQ |
Dec 11, 16:00
6.63
+0.03
(+0.45%)
After-Hours: 20:00
Vanda Pharmaceuticals Cash from Investing (Quarterly): 21.36M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| ADMA Biologics, Inc. | -14.37M |
| Aldeyra Therapeutics, Inc. | 25.00M |
| Exelixis, Inc. | 25.40M |
| Anavex Life Sciences Corp. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -31.63M |
| Cash from Financing (Quarterly) | -0.517M |
| Free Cash Flow | -82.95M |
| Free Cash Flow Per Share (Quarterly) | -0.5379 |
| Free Cash Flow to Equity (Quarterly) | -31.06M |
| Free Cash Flow to Firm (Quarterly) | -31.79M |
| Free Cash Flow Yield | -21.40% |